GNTLF - Genetic Technologies embraces global vision for genomic-integrated healthcare
(NewsDirect)
Genetic TechnologiesLtd (ASX:GTG) CEO Simon Morriss is back with Proactive’s ElishaNewell to outline the company’s latest endeavours in the predictivegenetics space. Lauded as a pioneer in clinical genetics tech, GTG isworking on early-stage tools that help clinicians and patientsproactively manage their health. Morriss says the company’s productsuite is geared towards personalised, non-invasive testing and riskassessments, all designed to accelerate a global transition togenomic-integrated healthcare.
ContactDetails
Proactive Investors
JonathanJackson
+61 413 713 744
jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.